PMID: 3748396Sep 1, 1986Paper

Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome

Neurology
D A ChadJ Sargent

Abstract

A 25-year-old man with multifocal weakness and fasciculation was thought to have motor neuron disease. Signs progressed for 1 year, plateaued, and 3 years later resolved almost completely. There was no evidence of paraproteinemia, lymphoproliferative disorder, or vasculitis, and myelography was normal. Electrodiagnostic study disclosed multifocal, acute and chronic denervation that evolved into a picture consistent with residuals of old multifocal radiculopathy without active denervation. Prolongation of F response, absence of H-reflex, and conduction block in a proximal nerve segment suggested multifocal demyelination. A proximal motor neuropathy, perhaps demyelinating, may cause some of the benign motor neuron syndromes that simulate motor neuron disease.

Citations

Nov 27, 2002·Muscle & Nerve·P SerorT Maisonobe
Sep 20, 2001·Muscle & Nerve·S R BeydounD Commins
Nov 13, 2004·Muscle & Nerve·Annie VerschuerenJean Pouget
Sep 1, 1993·Muscle & Nerve·D J LangeD M Blake
Apr 24, 2007·Journal of Neurology·Carel BulensPieter A van Doorn
Mar 22, 2013·Drugs·Eduardo Nobile-Orazio, Francesca Gallia
Dec 16, 1998·Journal of the Neurological Sciences·L P Rowland
Jul 16, 2002·Neuromuscular Disorders : NMD·Antonio ToscanoCorrado Messina
Jul 1, 1991·Acta Neurologica Scandinavica·I Hausmanowa-PetrusewiczA Kopeć
Aug 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·A GhoshM Donaghy
Jun 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·E Nobile-Orazio
Apr 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·J P AzulayG Serratrice
Jan 7, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·N MeucciE Nobile-Orazio
Apr 8, 1998·Annual Review of Neuroscience·T W HoJ W Griffin
Aug 3, 2011·Annals of Indian Academy of Neurology·Satish V KhadilkarPramod D Dhonde
Apr 15, 2014·Journal of Clinical Immunology·Oliver HarschnitzLeonard H van den Berg
Jul 2, 2014·Nature Reviews. Neurology·Norman Latov
Feb 1, 1991·Italian Journal of Neurological Sciences·P Di BellaF Angeleri
Sep 13, 2005·Current Opinion in Neurology·Jean-Marc Léger, Anthony Behin
Sep 3, 2013·Current Opinion in Neurology·Raquel Guimarães-CostaJean-Marc Léger
Feb 9, 2011·Expert Opinion on Biological Therapy·Filip Eftimov, Ivo N Van Schaik
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Laurent Magy, Jean-Michel Vallat
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Marc LégerCristina Muntean
May 1, 2013·La Presse médicale·Richard Hughes, Jean-Marc Léger
Apr 30, 2013·La Presse médicale·Raquel Guimarães-CostaJean-Marc Léger
Oct 31, 2012·Revue neurologique·E Fournier
Apr 17, 2010·La Revue de médecine interne·J FranquesS Attarian
Mar 17, 2005·Muscle & Nerve·Eduardo Nobile-OrazioAlberto Priori
Jan 11, 2005·Neurophysiologie clinique = Clinical neurophysiology·F Mesrati, M F Vecchierini
Jul 1, 1988·Annals of Neurology·A PestronkR N Adams
Oct 1, 1996·Electroencephalography and Clinical Neurophysiology·C P Panayiotopoulos, E Chroni
Apr 26, 2005·Lancet Neurology·Jan-Thies H Van AsseldonkLeonard H Van den Berg
Jul 7, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T W RattayA Grimm
May 6, 2015·Therapeutic Advances in Neurological Disorders·Jean-Marc LégerRuxandra Iancu Ferfoglia
Jan 1, 1989·Muscle & Nerve·P Van den BerghJ J Kelly
Aug 2, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·UNKNOWN European Federation of Neurological SocietiesP A van Doorn
Nov 23, 2011·Nature Reviews. Neurology·Lotte VlamLeonard H van den Berg
May 16, 2001·Muscle & Nerve·D S SapersteinR J Barohn
May 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·R N AuerM A Lee
Mar 5, 2015·The Cochrane Database of Systematic Reviews·T UmapathiJean-Marc Léger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.